Basal cell nevus syndrome is characterized by 5 major components, including multiple basal cell carcinomas, ectopic calcification of the falx cerebri, palmar or plantar pits, odontogenic jaw cysts, ... Rare Disease Consideration – Gorlin Syndrome: SkinJect also addresses the urgent unmet needs of patients with Gorlin syndrome (basal cell nevus syndrome), a rare genetic disorder affecting 1 in 31,000 ... Gorlin syndrome — also called basal cell nevus syndrome, nevoid basal cell carcinoma syndrome (NBCCS) and Gorlin-Goltz syndrome — is a rare genetic disorder that increases your risk of developing cancerous and benign (noncancerous) tumors.

Context Explanation

Basal cell nevus syndrome, also called Gorlin-Goltz syndrome, is a rare autosomal dominant cancer genetic syndrome. It increases the risk for childhood brain tumor, ovarian tumors, and skin cancer. Basal cell nevus syndrome or Gorlin syndrome is a rare dominantly inherited neurocutaneous syndrome characterized by the development of multiple basal cell carcinomas, jaw cysts, desmoplastic medulloblastoma, congenital skeletal abnormalities, and other neoplastic tumors. Gorlin syndrome, also called Gorlin-Goltz syndrome, basal cell nevus syndrome (BCNS), or nevoid basal cell carcinoma syndrome, is an autosomal dominant familial cancer syndrome.

Insight Material

Basal cell nevus syndrome is a group of irregularities caused by a rare genetic condition. Learn about the symptoms and treatments for basal cell nevus syndrome. Gorlin and Goltz (1960) described a familial syndrome comprising multiple nevoid basal-cell epitheliomas, jaw cysts, and bifid rib. Inheritance was autosomal dominant. Herzberg and Wiskemann (1963) described what they termed the 'fifth phakomatosis,' basal cell nevus syndrome with medulloblastoma.

Final Conclusion

Entry - #109400 - BASAL CELL NEVUS SYNDROME 1; BCNS1 - OMIM What is basal cell naevus syndrome? Basal cell naevus syndrome is a rare genetic cancer syndrome characterised by multiple early onset basal cell carcinomas, odontogenic keratocysts and other tumours, and other abnormalities. The overall objective of this guideline is to provide up‐to‐date, evidence‐based recommendations for the diagnosis and surveillance of all symptoms in children and adults with either basal cell naevus syndrome (BCNS), a clinical suspicion of BCNS, or a parent with BCNS. A guideline for the clinical management of basal cell naevus syndrome ...